Any use outside lawful scientific research is outside the scope of sale.
(6.1) Chronic Rhinosinusitis with Nasal Polyps (incidence 1%): injection site reactions, eosinophilia, insomnia, toothache, gastritis, arthralgia, and conjunctivitis
For pure weight-loss endpoints, retatrutide outperforms semaglutide by roughly 9 percentage points at peak dose: 24.2% versus ~15% mean body-weight loss at comparable durations [3][4]
Licensed clinician participation is limited to intake review and prescribing decisions outside platform control
Some are even going into long-term remission
doi:10.1016/S2213-8587(17)30092-4 Pratley RE, Aroda VR, Lingvay I, et al